Literature DB >> 9257014

The role of respiratory viruses in asthma.

W W Busse1, J E Gern, E C Dick.   

Abstract

Respiratory infections are common causes of increased asthma for patients of all ages. Current evidence indicates that viral, and not bacterial, infections are the most important respiratory illnesses which increase the severity of asthma. Of the respiratory viral infections associated with increased asthma, rhinoviruses, i.e. the cause of common colds, have proven to be the virus most often found in association with increased asthma severity. Although the association between rhinovirus infections and asthma is most dramatically illustrated in children, asthma patients of all ages can be affected and the attacks of asthma can be severe. Studies to establish the mechanisms by which rhinoviruses enhance asthma severity have begun to focus on how this virus promotes allergic inflammation. We have found that experimental rhinovirus infections enhance airway responsiveness and, perhaps most importantly, the likelihood that a late allergic reaction will occur to an antigen challenge. Furthermore, using bronchoscopy and segmental antigen challenge, we have found that rhinovirus infections promote mast cell release of histamine and the recruitment of eosinophils to the airways. These data support the concept that rhinovirus infections act to promote allergic inflammation and by this mechanism increase both the likelihood of asthma occurring and the severity of wheezing.

Entities:  

Mesh:

Year:  1997        PMID: 9257014     DOI: 10.1002/9780470515334.ch13

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  11 in total

Review 1.  Review of psychosocial stress and asthma: an integrated biopsychosocial approach.

Authors:  R J Wright; M Rodriguez; S Cohen
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

2.  Comparison of rhinovirus A infection in human primary epithelial and HeLa cells.

Authors:  S P Amineva; A G Aminev; J E Gern; A C Palmenberg
Journal:  J Gen Virol       Date:  2011-07-13       Impact factor: 3.891

3.  Mas-related G protein coupled receptor-X2: A potential new target for modulating mast cell-mediated allergic and inflammatory diseases.

Authors:  Hydar Ali
Journal:  J Immunobiol       Date:  2016-12-28

4.  Respiratory syncytial virus infection modifies and accelerates pulmonary disease via DC activation and migration.

Authors:  Sihyug Jang; Joost Smit; Lara E Kallal; Nicholas W Lukacs
Journal:  J Leukoc Biol       Date:  2013-01-04       Impact factor: 4.962

5.  Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation.

Authors:  D A Randolph; R Stephens; C J Carruthers; D D Chaplin
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

6.  Effects of chloro-s-triazine herbicides and metabolites on aromatase activity in various human cell lines and on vitellogenin production in male carp hepatocytes.

Authors:  J T Sanderson; R J Letcher; M Heneweer; J P Giesy; M van den Berg
Journal:  Environ Health Perspect       Date:  2001-10       Impact factor: 9.031

Review 7.  Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases.

Authors:  Hariharan Subramanian; Kshitij Gupta; Hydar Ali
Journal:  J Allergy Clin Immunol       Date:  2016-07-20       Impact factor: 10.793

8.  Presence of asthma risk factors and environmental exposures related to upper respiratory infection-triggered wheezing in middle school-age children.

Authors:  Mark Sotir; Karin Yeatts; Carl Shy
Journal:  Environ Health Perspect       Date:  2003-04       Impact factor: 9.031

9.  Violence: an unrecognized environmental exposure that may contribute to greater asthma morbidity in high risk inner-city populations.

Authors:  R J Wright; S F Steinbach
Journal:  Environ Health Perspect       Date:  2001-10       Impact factor: 9.031

10.  Iron deficiency associated with higher blood lead in children living in contaminated environments.

Authors:  A Bradman; B Eskenazi; P Sutton; M Athanasoulis; L R Goldman
Journal:  Environ Health Perspect       Date:  2001-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.